Availability of locally synthesized and systemic antibodies in the intestine.
The present studies are concerned with the parameters which control the appearance of locally synthesized or serum-derived antibodies in the intestine. The data show that intestinal antibody may be found in rabbits as well as in conventional or germfree mice after active immunization with Vibrio cholerae. However, a large fraction of the intestinal antibody in rabbits and conventional mice originated from the serum as indicated by (i) analysis of correlation between serum and intestinal antibody titers, and (ii) the occurrence of intestinal antibody after parenteral administration of antiserum. In contrast, only locally synthesized 11S immunoglobulin A antibody was detected in the intestine of actively immunized germfree mice. No intestinal antibody was demonstrable in germfree mice after parenteral injection of V. cholerae antiserum. With respect to the appearance of serum antibody in the intestine, the response of conventionalized (ex-germfree) mice was intermediate between that of rabbits or conventional mice and germfree mice. The availability of serum-derived coproantibody in germfree and conventional mice was related to the rates of intestinal degradation of serum antibody. When enzymes were removed by prior washing of intestinal segments, serum antibodies entered the intestine of germfree or conventional mice at similar rates. Rates of entry of serum antibodies into the lumen were comparable at different levels of the small intestine. The presence of a normal enteric flora appeared to protect intestinal antibody from degradation by lowering the concentration or activity of intestinal enzymes. The results are discussed in relation to the question of whether antibacterial immunity to cholera involves local or systemic mechanisms.
D000284:Administration, Oral; D000372:Agglutination Tests; D000818:Animals; D000906:Antibodies / Q000032:analysis* / Q000145:classification; D000917:Antibody Formation; D002499:Centrifugation, Density Gradient; D003126:Colostrum / Q000276:immunology; D003165:Complement System Proteins; D004586:Electrophoresis; D005856:Germ-Free Life; D006041:Goats / Q000276:immunology; D006168:Guinea Pigs; D007106:Immune Sera; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007421:Intestine, Small / Q000276:immunology; D007422:Intestines / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D011817:Rabbits; D014733:Vibrio / Q000276:immunology; D014765:Viral Vaccines
D000906:Antibodies; D007106:Immune Sera; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014765:Viral Vaccines; D003165:Complement System Proteins